
浏览全部资源
扫码关注微信
纸质出版日期:2012
移动端阅览
陈丽, 张绪东, 焦杨, 等. 玉郎伞提取物对食饵性高脂血症大鼠肝脏脂蛋白代谢相关酶活性及脂肪肝的影响[J]. 中国实验方剂学杂志, 2012,18(9):254-258.
CHEN Li, ZHANG Xu-dong, JIAO Yang, et al. Effects of Yulangsan Extracts on Enzymes of Lipoprotein Metabolism and Fatty Liver in Hyperlipidemic Rats Induced by High Fat Diet[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(9): 254-258.
陈丽, 张绪东, 焦杨, 等. 玉郎伞提取物对食饵性高脂血症大鼠肝脏脂蛋白代谢相关酶活性及脂肪肝的影响[J]. 中国实验方剂学杂志, 2012,18(9):254-258. DOI:
CHEN Li, ZHANG Xu-dong, JIAO Yang, et al. Effects of Yulangsan Extracts on Enzymes of Lipoprotein Metabolism and Fatty Liver in Hyperlipidemic Rats Induced by High Fat Diet[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(9): 254-258. DOI:
目的: 研究玉郎伞(YLS)块根提取物(包括总黄酮、多糖及其水提物)对食饵性高脂血症大鼠肝脏脂蛋白代谢相关酶活性及肝脏脂肪变性的影响。 方法: 用高脂膳食饲喂SD大鼠6周
造成饵食性高脂血症
将高脂血症大鼠按照血清总胆固醇(TC)水平随机分成高脂模型组、YLS总黄酮高剂量组(YFH)、YLS总黄酮低剂量组(YFL)、YLS多糖高剂量组(YPH)、YLS多糖低剂量组(YPL)、YLS水提物高剂量组(YAH)、YLS水提物低剂量组(YAL)和洛伐他汀组8组
每组10只。空白组和高脂模型组均灌服空白溶剂15 g·kg-1·d-1;洛伐他汀组灌服洛伐他汀溶液3.0 mg·kg-1·d-1;YFH
YFL组分别灌服YLS总黄酮0.1
0.025 g·kg-1·d-1;YPH
YPL组分别灌服YLS多糖0.15
0.037 5 g·kg-1·d-1;YAH
YAL组分别灌服YLS水提物15.00
3.75 g生药·kg-1·d-1。连续给药14 d后检测各组大鼠脂蛋白酯酶(LPL)、肝酯酶(HL)、超氧化物歧化酶(SOD)、丙二醛(MDA)和血脂TC、甘油三酯(TG)、低密度脂蛋白-胆固醇(LDL-C)水平等各项指标
用HE染色法观察大鼠肝组织病理形态学改变情况。 结果: 与高脂模型组比较
各用药组TC
TG
LDL-C
MDA水平降低
HDL-C
LPL
HL和SOD水平升高(P<0.01或P<0.05)
肝组织脂肪变性情况有不同程度改善
其中YFH、YFL组改善效果最明显。 结论: YLS提取物对饵食性高脂血症大鼠脂质代谢紊乱有显著的调节作用
能有效缓解高脂性脂肪变性
其机制可能与其能提高肝脏脂蛋白代谢相关酶和SOD的活性有关。
Objective: To explore the effects of the Yulangsan (YLS) extracts (YLS flavonoids
polysaccharide and aqueous extract) on enzymes of lipoprotein metabolism and fatty liver in the hyperlipidemic rats induced by high fat diet. Method : Eighty healthy SD rats were raised by hyper-fatty feed for 6 weeks to induce the hyperlipidemia rat model. Then the rats were divided into 8 groups randomly according to their serum TC: model group
high dose group of YLS flavonoids (YFH)
low dose group of YLS flavonoids (YFL)
high dose group of YLS polysaccharide (YPH)
low dose group of YLS polysaccharide (YPL)
high dose group of YLS aqueous extract (YAH)
low dose group of YLS aqueous extract (YAL) and lovastatin group. Model group and blank control group were given with vehicles (15 g·kg-1·d-1)
lovastatin group was given with lovastatin solution (3.0 mg·kg-1·d-1)
YFH and YFL groups were given with YLS flavonoids (0.1 g·kg-1·d-1 and 0.025 g·kg-1·d-1 respectively)
YPH and YPL groups were given with YLS polysaccharide (0.15 g·kg-1·d-1 and 0.037 5 g·kg-1·d-1 respectively)
YAH and YAL groups were given with YLS aqueous extract (15.00 g·kg-1·d-1 and 3.75 g·kg-1·d-1 respectively). Serum lipoprotein level
lipoprotein lipase (LPL)
hepatic lipase (HL)
superoxide dismutase (SOD) and malondialdehyda (MDA) were tested after treated with corresponding drugs once per day for 14 days
and the changes of pathomorphology of liver tissue were observed by HE dye. Result :Compared with the model group
the levels of the serum TC
TG
LDL-C
and MDA were decreased significantly
while HDL-C
LPL
HL and SOD were increased significantly (P<0.05 or P<0.01). In all treated groups
the liver weight
liver coefficient decreased significantly
and the liver adipose degeneration was ameliorated in some degree after the treatment with YLS extracts. High- and low-dose groups of YLS flavonoids had especially the most obvious improved effects. Conclusion: The lipid metabolic disorder and the liver adipose degeneration in hyperlipidemia rats were improved significantly after the treatment with YLS extracts
which may be related with the increase on enzyme activity of lipoprotein metabolism and SOD.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621